Antibody Shuttles Could Deliver Noninvasive Drugs Directly to Brain to Treat Alzheimer’s

Oct. 22, 2026
•
Read time: <5 mins
GettyImages 1367871877

Getting medicine into the brain is one of the biggest challenges in treating Alzheimer’s disease. With a $3.1 million NIH grant, U-M researchers are exploring a new way to deliver genetic treatments to the brain through a standard IV.

Share:
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.